Cite
HARVARD Citation
Huang, M. et al. (n.d.). 110PEvaluation of pathological complete response as a trial-level surrogate for long-term survival outcomes among triple-negative breast cancer patients receiving neoadjuvant therapy. Annals of oncology. p. . [Online].